
PETER HARPER, Guy’s Hospital, London
Bisphosphonates may be more suited for improving the outlook among patients with lung cancer who have bone metastases compared to palliative …

DAVID JABLONS, University of California, San Francisco
![]() Rachel Johnson |
![]() Terry Mamounas |
![]() William Gradishar |
REFERENCE: Abstract: 2090
RACHEL JOHNSON, Christie Hospital, Manchester
Some patients with HER-2 positive early breast cancer fare better if trastuzumab is withheld, according to
…
![]() Francis Giles |
![]() Ken Kaushansky |
![]() Heather Leitch |
![]() Nancy Berliner |
![]() Corrado Tarella |
![]() Vincent Rajkumar |
![]() Robert Kyle |
REFERENCE: Abstract: 163
FRANCIS GILES, M D Anderson Cancer Center, Houston
COMMENT: KEN
…
![]() Martin Müller |
![]() Charles Linker |
![]() Andreas Hochhaus |
![]() Christian Buske |
![]() Katarina Le Blanc |
![]() Stephen Emerson |
![]() Alessandro Vannucchi |
![]() Kanti Rai |
![]() Richard Schlenk |
REFERENCE: American Society of Hematology 2006 Orlando: Abstract: 748
MARTIN MÜLLER,
…
![]() Clifford Hudis |
![]() Mark Einstein |
![]() Tony Greco |
![]() James Berenson |
![]() Edward Ambinder |
REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
CLIFFORD HUDIS, Memorial Sloan-Kettering Cancer Center, New York
COMMENT: EDWARD AMBINDER, Mount
…
![]() Daniel Petrylak |
![]() Oliver Sartor |
![]() Mark Socinski |
![]() Kanti Rai |
![]() Edward Ambinder |
REFERENCE: Chemotherapy Foundation Symposium XXIV 8-11 November 2006
DANIEL PETRYLAK, Columbia Presbyterian Medical Center, New York
COMMENT: EDWARD AMBINDER, Mount
…
![]() Mark Socinski |
![]() Bruce Johnson |
![]() Neil Shah |
![]() Doug Smith |
REFERENCE: Abstract 7001
Mark A. Socinski, Univerisity of North Carolina, Chapel Hill
The use of anti-angiogenic therapy for treating patients with non-small cell
…